SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-011912
Filing Date
2022-06-21
Accepted
2022-06-21 17:05:13
Documents
19
Period of Report
2022-06-21
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crsp-20220621.htm   iXBRL 8-K 58461
2 EX-99.1 crsp-ex99_1.htm EX-99.1 9025
3 GRAPHIC crsp-ex99_1s1.jpg GRAPHIC 64306
4 GRAPHIC crsp-ex99_1s2.jpg GRAPHIC 149411
5 GRAPHIC crsp-ex99_1s3.jpg GRAPHIC 62207
6 GRAPHIC crsp-ex99_1s4.jpg GRAPHIC 71773
7 GRAPHIC crsp-ex99_1s5.jpg GRAPHIC 62714
8 GRAPHIC crsp-ex99_1s6.jpg GRAPHIC 66004
  Complete submission text file 0000950170-22-011912.txt   842893

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crsp-20220621.xsd EX-101.SCH 2464
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crsp-20220621_lab.xml EX-101.LAB 12743
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crsp-20220621_pre.xml EX-101.PRE 10470
13 EXTRACTED XBRL INSTANCE DOCUMENT crsp-20220621_htm.xml XML 4500
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37923 | Film No.: 221028909
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences